Veterans With COVID-19 Given Trump-Touted Hydroxychloroquine Showed No Benefits, Study Finds

 In a retrospective study, which has not yet been peer-reviewed, doctors examined patient outcomes for U.S. military veterans with COVID-19 who were given hydroxychloroquine (an anti-malaria drug touted by President Trump as coronavirus treatment) and compared them to patients who did not receive that treatment; the researchers concluded there was no overall benefit—and that there were more deaths among patients treated with hydroxychloroquine alone.